<DOC>
	<DOCNO>NCT00847145</DOCNO>
	<brief_summary>The propose study Extension Study V72P13 Evaluate Safety , Tolerability Immunogenicity Novartis Meningococcal B Recombinant Vaccine When Administered Booster 12 Months Age Two-dose Catch-up Healthy Toddlers</brief_summary>
	<brief_title>Extension Study V72P13 Evaluate Safety , Tolerability Immunogenicity Novartis Meningococcal B Recombinant Vaccine When Administered Booster Two-dose Catch-up Healthy Toddlers</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy 12monthold toddler ( 0/ +29 day ) complete Study V72P13 Previous ascertain suspected disease cause N. meningitidis ; History severe allergic reaction previous vaccination hypersensitivity vaccine component ; Any serious chronic progressive disease Known suspect impairment/ alteration immune system , Receipt , intent immunize another vaccine , within 30 day prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>365 Days</minimum_age>
	<maximum_age>394 Days</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>toddler</keyword>
	<keyword>Meningococcal disease</keyword>
	<keyword>prevention</keyword>
	<keyword>vaccination</keyword>
</DOC>